Sign in
4

Changes in Ownership

Aclaris Therapeutics, Inc. Filed Acc 0001209191-24-004385

Director bought 14,500 shares at an average $1.24 ($17,955)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Powell Andrew Kenneth William Director 2024-03-01 Purchase +8,500 $1.23 $10,455 22,863 D
Powell Andrew Kenneth William Director 2024-03-04 Purchase +6,000 $1.25 $7,500 28,863 D
Open-market purchases · 14,500 sh · avg $1.24 · $17,955
Loading xslF345X05/doc4.xml…